Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20191111045408N1
IRCT20191111045408N1
Not yet recruiting
Phase 3

Evaluation of the effect of topical formulation prepared from hydroalcoholic extract of Arctium Lappa's root in the treatment of mild and moderate Acne Vulgaris

Mashhad University of Medical Sciences0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
100
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Women and men aged 12\-30 years with mild to moderate acne vulgaris
  • •Have signed the informed consent form

Exclusion Criteria

  • •Pregnant or breastfeeding or planning to become pregnant
  • •Have a history of sensitivity to the components of the formulations used in the study
  • •Other skin diseases such as eczema that make it difficult to evaluate the response to treatment
  • •Have uncontrolled systemic disease
  • •They have Acne Conglobata
  • •Not taking the following drugs before starting the plan (topical anti\-acne drugs for two weeks, oral antibiotics for one month, 12 weeks hormone therapy and 6 months oral retinoids).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
The evaluation of efficacy of topical formulation of Henna (Lawsonia inermis) in prevention of contact dermatitis in patients using prosthesis
IRCT20171229038126N1Kerman University of Medical Sciences72
Recruiting
Phase 3
Evaluation of the effect of topical whey protein on the prevention of pressure ulcerpressure ulcer.Pressure ulcer
IRCT20150221021159N2Esfahan University of Medical Sciences80
Active, not recruiting
Phase 1
Evaluation of the efficacy of a topical formulation containing ASF-1075 in the treatment of chronic hand dermatitis - hand dermatitismale or female patients with chronic hand dermatitis, aged 18 to 70 yearsMedDRA version: 8.1Level: LLTClassification code 10058898Term: Hand dermatitis
EUCTR2005-005793-75-DEAstion Danmark A/S40
Active, not recruiting
Not Applicable
Evaluation of the efficacy of a topical formulation containing ASF-1075 in the treatment of chronic hand dermatitis - hand dermatitis
EUCTR2005-005793-75-DKAstion Danmark A/S40
Active, not recruiting
Not Applicable
Evaluation of the efficacy of topical formulations containing ASF-1075 in the prevention and treatment of contact dermatitis - contact dermatitis
EUCTR2005-005792-15-DEAstion Danmark A/S20